進藤 岳郎

Last Update: 2021/06/14 19:38:37

Print

Name(Kanji/Kana/Abecedarium Latinum)
進藤 岳郎/シンドウ タケロウ/Shindo, Takero
Primary Affiliation(Org1/Job title)
Kyoto University Hospital Kyoto University Hospital/Assistant Professor
E-mail Address
E-mail address
takeros @ kuhp.kyoto-u.ac.jp
Academic Organizations You are Affiliated to in Japan
Organization name(Japanese) Organization name(English)
日本内科学会 The Japanese Society of Internal Medicine
日本血液学会 The Japanese Society of Hematology
日本造血細胞移植学会 The Japanese Society of Hematopoietic Cell Transplantation
日本HTLV-1学会 The Japanese Society of HTLV-1 and associated diseases
日本組織適合性学会 The Japanese Society for Histocompatibility and Immunogenetics
日本臨床検査医学会 The Japanese Society of Laboratory Medicine
血液疾患免疫療法学会 The Japanese Society of Immunotherapy for Hematological Disorders
日本臨床免疫学会 The Japanese Society of Clinical Immunology
日本癌学会 Japanese Cancer Association
Academic Degree
Field(Japanese) Field(English) University(Japanese) University(English) Method
博士(医学) 京都大学
Work Experience
Period Organization(Japanese) Organization(English) Job title(Japanese) Job title(English)
1997/05/01-1998/05/31 京都大学医学部附属病院 医員(研修医) Resident
1998/06/01-2000/05/31 神鋼病院 医員(研修医) Resident
2000/06/01-2002/03/31 市立長浜病院 医員 Clinical Fellow
2007/04/01-2008/12/31 関西電力病院 医員 Clinical Fellow
2009/02/01-2010/06/30 フレッドハッチンソン癌研究センター Fred Hutchinson Cancer Research Center 博士研究員 Post-doctoral research fellow
2010/07/01-2012/06/30 マイアミ大学シルベスター癌センター University of Miami Sylvester Comprehensive Cancer Center 博士研究員 Post-doctoral research fellow
2012/08/01-2016/10/31 佐賀大学医学部血液・呼吸器・腫瘍内科 助教 Assistant Professor
2016/11/01- 京都大学医学部附属病院 助教 Assistant Professor
Personal Profile
(Japanese)
血液内科全般の診療活動に携わりつつ、造血幹細胞移植を含めた各種治療法の最適化を目指している。専門とするのは免疫学で、移植医療やがん医療全般への応用を試みている。またHTLV-1や血液疾患全般の啓発活動にも力を入れている。
(English)
I am involved in clinical activity of hematology, and am also trying to improve several therapeutic modalities including hematopoietic stem cell transplantation. Through immunological approaches, I am trying to apply novel methodologies in transplant and oncology areas. In addition, I also conduct enlightenment activity in HTLV-1 and other hematologic diseases.
Language of Instruction
Language(japanese) Language(english) Code
日本語 Japanese jpn
英語 English eng
ORCID ID
https://orcid.org/0000-0002-2085-6151
researchmap URL
https://researchmap.jp/7000018457
Research Topics
(Japanese)
移植免疫学、腫瘍免疫学
(English)
Transplant immunology, Tumor immunology
Overview of the research
(Japanese)
同種造血幹細胞移植におけるGVHDとGVTの最適化
(English)
Manipulating GVHD and GVT in allogeneic hematopoietic stem cell transplantation
Published Papers
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
Misa Noguchi, Takero Shindo, Yosuke Yamada, Hiroshi Date Misa Noguchi, Takero Shindo, Yosuke Yamada, Hiroshi Date Misa Noguchi, Takero Shindo, Yosuke Yamada, Hiroshi Date T-cell chimerism prior to graft-versus-host disease T-cell chimerism prior to graft-versus-host disease T-cell chimerism prior to graft-versus-host disease European Journal of Cardio-Thoracic Surgery European Journal of Cardio-Thoracic Surgery European Journal of Cardio-Thoracic Surgery 2021/01/25 Refereed English Research paper(scientific journal) Disclose to all
Hideaki Tsuji, Hajime Yoshifuji, Takero Shindo, Masakatsu Hishizawa, Ayami Ishida, Masakazu Fujimoto, Koji Kitagori, Shuji Akizuki, Kosaku Murakami, Ran Nakashima, Motomu Hashimoto, Masao Tanaka, Koichiro Ohmura Hideaki Tsuji, Hajime Yoshifuji, Takero Shindo, Masakatsu Hishizawa, Ayami Ishida, Masakazu Fujimoto, Koji Kitagori, Shuji Akizuki, Kosaku Murakami, Ran Nakashima, Motomu Hashimoto, Masao Tanaka, Koichiro Ohmura Hideaki Tsuji, Hajime Yoshifuji, Takero Shindo, Masakatsu Hishizawa, Ayami Ishida, Masakazu Fujimoto, Koji Kitagori, Shuji Akizuki, Kosaku Murakami, Ran Nakashima, Motomu Hashimoto, Masao Tanaka, Koichiro Ohmura Primary hepatic lymphoma as other iatrogenic immunodeficiency-related lymphoproliferative disorders: a case report and review of the literature Primary hepatic lymphoma as other iatrogenic immunodeficiency-related lymphoproliferative disorders: a case report and review of the literature Primary hepatic lymphoma as other iatrogenic immunodeficiency-related lymphoproliferative disorders: a case report and review of the literature Modern Rheumatology Case Reports, 5, 1, 172-177 Modern Rheumatology Case Reports, 5, 1, 172-177 Modern Rheumatology Case Reports, 5, 1, 172-177 2021/01/02 Refereed English Research paper(scientific journal) Disclose to all
Hiroshi Ureshino, Takero Shindo, Hidenori Tanaka, Hiroh Saji, Shinya Kimura Hiroshi Ureshino, Takero Shindo, Hidenori Tanaka, Hiroh Saji, Shinya Kimura Hiroshi Ureshino, Takero Shindo, Hidenori Tanaka, Hiroh Saji, Shinya Kimura HLA Polymorphisms Are Associated with Treatment-Free Remission Following Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia HLA Polymorphisms Are Associated with Treatment-Free Remission Following Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia HLA Polymorphisms Are Associated with Treatment-Free Remission Following Discontinuation of Tyrosine Kinase Inhibitors in Chronic Myeloid Leukemia Molecular Cancer Therapeutics, 20, 1, 142-149 Molecular Cancer Therapeutics, 20, 1, 142-149 Molecular Cancer Therapeutics, 20, 1, 142-149 2021/01 Refereed English Research paper(scientific journal) Disclose to all
Masaaki Hirata, Shintaro Yagi, Takero Shindo, Atsushi Yoshizawa, Gozo Kiguchi, Masakatsu Kaneshiro, Kimiko Yurugi, Yosuke Miyachi, Sena Iwamura, Siyuan Yao, Shinji Uemoto Masaaki Hirata, Shintaro Yagi, Takero Shindo, Atsushi Yoshizawa, Gozo Kiguchi, Masakatsu Kaneshiro, Kimiko Yurugi, Yosuke Miyachi, Sena Iwamura, Siyuan Yao, Shinji Uemoto Masaaki Hirata, Shintaro Yagi, Takero Shindo, Atsushi Yoshizawa, Gozo Kiguchi, Masakatsu Kaneshiro, Kimiko Yurugi, Yosuke Miyachi, Sena Iwamura, Siyuan Yao, Shinji Uemoto Donor‐dominant one‐way matching of human leukocyte antigen‐A/B/DR alleles predicts graft‐versus‐host disease following living donor liver transplantation Donor‐dominant one‐way matching of human leukocyte antigen‐A/B/DR alleles predicts graft‐versus‐host disease following living donor liver transplantation Donor‐dominant one‐way matching of human leukocyte antigen‐A/B/DR alleles predicts graft‐versus‐host disease following living donor liver transplantation Hepatology Research, 51, 1, 135-148 Hepatology Research, 51, 1, 135-148 Hepatology Research, 51, 1, 135-148 2021/01 Refereed English Research paper(scientific journal) Disclose to all
Hiroyuki Muranushi, Takero Shindo, Masakatsu Hishizawa, Masahito Tokunaga, Atsushi Wake, Nobuaki Nakano, Tetsuya Eto, Michihiro Hidaka, Ilseung Choi, Toshihiro Miyamoto, Naoyuki Uchida, Yukiyoshi Moriuchi, Yasuhiko Miyazaki, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, Koji Kato Hiroyuki Muranushi, Takero Shindo, Masakatsu Hishizawa, Masahito Tokunaga, Atsushi Wake, Nobuaki Nakano, Tetsuya Eto, Michihiro Hidaka, Ilseung Choi, Toshihiro Miyamoto, Naoyuki Uchida, Yukiyoshi Moriuchi, Yasuhiko Miyazaki, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, Koji Kato Hiroyuki Muranushi, Takero Shindo, Masakatsu Hishizawa, Masahito Tokunaga, Atsushi Wake, Nobuaki Nakano, Tetsuya Eto, Michihiro Hidaka, Ilseung Choi, Toshihiro Miyamoto, Naoyuki Uchida, Yukiyoshi Moriuchi, Yasuhiko Miyazaki, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, Koji Kato GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma GVHD-free, relapse-free survival provides novel clues for optimizing allogeneic-HSCT for adult T-cell leukemia/lymphoma Bone Marrow Transplantation, 56, 1, 155-166 Bone Marrow Transplantation, 56, 1, 155-166 Bone Marrow Transplantation, 56, 1, 155-166 2021/01 Refereed English Research paper(scientific journal) Disclose to all
Fumiya Wada, Momoko Nishikori, Masakatsu Hishizawa, Mitsumasa Watanabe, Akiko Aiba, Toshiyuki Kitano, Yayoi Shimazu, Takero Shindo, Tadakazu Kondo, Akifumi Takaori-Kondo Fumiya Wada, Momoko Nishikori, Masakatsu Hishizawa, Mitsumasa Watanabe, Akiko Aiba, Toshiyuki Kitano, Yayoi Shimazu, Takero Shindo, Tadakazu Kondo, Akifumi Takaori-Kondo Fumiya Wada, Momoko Nishikori, Masakatsu Hishizawa, Mitsumasa Watanabe, Akiko Aiba, Toshiyuki Kitano, Yayoi Shimazu, Takero Shindo, Tadakazu Kondo, Akifumi Takaori-Kondo Secondary failure of platelet recovery in patients treated with high-dose thiotepa and busulfan followed by autologous stem cell transplantation Secondary failure of platelet recovery in patients treated with high-dose thiotepa and busulfan followed by autologous stem cell transplantation Secondary failure of platelet recovery in patients treated with high-dose thiotepa and busulfan followed by autologous stem cell transplantation International Journal of Hematology, 112, 5, 609-613 International Journal of Hematology, 112, 5, 609-613 International Journal of Hematology, 112, 5, 609-613 2020/11 Refereed English Research paper(scientific journal) Disclose to all
Yui Matsuoka, Yoshiki Iemura, Masakazu Fujimoto, Shinsuke Shibuya, Atsushi Yamada, Shigehiko Fujii, Toshihiro Kusaka, Takero Shindo, Sachiko Minamiguchi, Hironori Haga Yui Matsuoka, Yoshiki Iemura, Masakazu Fujimoto, Shinsuke Shibuya, Atsushi Yamada, Shigehiko Fujii, Toshihiro Kusaka, Takero Shindo, Sachiko Minamiguchi, Hironori Haga Yui Matsuoka, Yoshiki Iemura, Masakazu Fujimoto, Shinsuke Shibuya, Atsushi Yamada, Shigehiko Fujii, Toshihiro Kusaka, Takero Shindo, Sachiko Minamiguchi, Hironori Haga Upper Gastrointestinal Langerhans Cell Histiocytosis: A Report of 2 Adult Cases and a Literature Review Upper Gastrointestinal Langerhans Cell Histiocytosis: A Report of 2 Adult Cases and a Literature Review Upper Gastrointestinal Langerhans Cell Histiocytosis: A Report of 2 Adult Cases and a Literature Review International Journal of Surgical Pathology, 106689692096456-106689692096456 International Journal of Surgical Pathology, 106689692096456-106689692096456 International Journal of Surgical Pathology, 106689692096456-106689692096456 2020/10/09 Refereed English Research paper(scientific journal) Disclose to all
Seiichiro Tada, Takayuki Anazawa, Takero Shindo, Kei Yamane, Kenta Inoguchi, Nanae Fujimoto, Kazuyuki Nagai, Toshihiko Masui, Hideaki Okajima, Kyoichi Takaori, Shoichiro Sumi, Shinji Uemoto Seiichiro Tada, Takayuki Anazawa, Takero Shindo, Kei Yamane, Kenta Inoguchi, Nanae Fujimoto, Kazuyuki Nagai, Toshihiko Masui, Hideaki Okajima, Kyoichi Takaori, Shoichiro Sumi, Shinji Uemoto Seiichiro Tada, Takayuki Anazawa, Takero Shindo, Kei Yamane, Kenta Inoguchi, Nanae Fujimoto, Kazuyuki Nagai, Toshihiko Masui, Hideaki Okajima, Kyoichi Takaori, Shoichiro Sumi, Shinji Uemoto The MEK Inhibitor Trametinib Suppresses Major Histocompatibility Antigen-mismatched Rejection Following Pancreatic Islet Transplantation The MEK Inhibitor Trametinib Suppresses Major Histocompatibility Antigen-mismatched Rejection Following Pancreatic Islet Transplantation The MEK Inhibitor Trametinib Suppresses Major Histocompatibility Antigen-mismatched Rejection Following Pancreatic Islet Transplantation Transplantation Direct, 6, 9, e591-e591 Transplantation Direct, 6, 9, e591-e591 Transplantation Direct, 6, 9, e591-e591 2020/09 Refereed English Research paper(scientific journal) Disclose to all
Saiko Kurosawa, Hiroki Yamaguchi, Takuhiro Yamaguchi, Keiko Fukunaga, Shunsuke Yui, Heiwa Kanamori, Kensuke Usuki, Nobuhiko Uoshima, Masamitsu Yanada, Jin Takeuchi, Ishikazu Mizuno, Junya Kanda, Hiroshi Okamura, Shingo Yano, Haruko Tashiro, Takero Shindo, Shigeru Chiba, Junji Tomiyama, Koiti Inokuchi, Takahiro Fukuda Saiko Kurosawa, Hiroki Yamaguchi, Takuhiro Yamaguchi, Keiko Fukunaga, Shunsuke Yui, Heiwa Kanamori, Kensuke Usuki, Nobuhiko Uoshima, Masamitsu Yanada, Jin Takeuchi, Ishikazu Mizuno, Junya Kanda, Hiroshi Okamura, Shingo Yano, Haruko Tashiro, Takero Shindo, Shigeru Chiba, Junji Tomiyama, Koiti Inokuchi, Takahiro Fukuda Saiko Kurosawa, Hiroki Yamaguchi, Takuhiro Yamaguchi, Keiko Fukunaga, Shunsuke Yui, Heiwa Kanamori, Kensuke Usuki, Nobuhiko Uoshima, Masamitsu Yanada, Jin Takeuchi, Ishikazu Mizuno, Junya Kanda, Hiroshi Okamura, Shingo Yano, Haruko Tashiro, Takero Shindo, Shigeru Chiba, Junji Tomiyama, Koiti Inokuchi, Takahiro Fukuda The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse The prognostic impact of FLT3-ITD, NPM1 and CEBPa in cytogenetically intermediate-risk AML after first relapse International Journal of Hematology, 112, 2, 200-209 International Journal of Hematology, 112, 2, 200-209 International Journal of Hematology, 112, 2, 200-209 2020/08 Refereed English Research paper(scientific journal) Disclose to all
Takero Shindo, Hiroshi Ureshino, Hiroto Kojima, Hidenori Tanaka, Shinya Kimura Takero Shindo, Hiroshi Ureshino, Hiroto Kojima, Hidenori Tanaka, Shinya Kimura Takero Shindo, Hiroshi Ureshino, Hiroto Kojima, Hidenori Tanaka, Shinya Kimura Allelic polymorphisms of KIRs and antitumor immunity against chronic myeloid leukemia Allelic polymorphisms of KIRs and antitumor immunity against chronic myeloid leukemia Allelic polymorphisms of KIRs and antitumor immunity against chronic myeloid leukemia Immunological Medicine, 1-8 Immunological Medicine, 1-8 Immunological Medicine, 1-8 2020/07/25 Refereed English Research paper(scientific journal) Disclose to all
Hiroyuki Muranushi, Junya Kanda, Yasuyuki Arai, Takero Shindo, Masakatsu Hishizawa, Takashi Yamamoto, Tadakazu Kondo, Kohei Yamashita, Kazuo Matsubara, Akifumi Takaori‐Kondo Hiroyuki Muranushi, Junya Kanda, Yasuyuki Arai, Takero Shindo, Masakatsu Hishizawa, Takashi Yamamoto, Tadakazu Kondo, Kohei Yamashita, Kazuo Matsubara, Akifumi Takaori‐Kondo Hiroyuki Muranushi, Junya Kanda, Yasuyuki Arai, Takero Shindo, Masakatsu Hishizawa, Takashi Yamamoto, Tadakazu Kondo, Kohei Yamashita, Kazuo Matsubara, Akifumi Takaori‐Kondo Drug monitoring for mycophenolic acid in graft‐ vs ‐host disease prophylaxis in cord blood transplantation Drug monitoring for mycophenolic acid in graft‐ vs ‐host disease prophylaxis in cord blood transplantation Drug monitoring for mycophenolic acid in graft‐ vs ‐host disease prophylaxis in cord blood transplantation British Journal of Clinical Pharmacology British Journal of Clinical Pharmacology British Journal of Clinical Pharmacology 2020/05/30 Refereed Research paper(scientific journal) Disclose to all
Hiroshi Ureshino, Takero Shindo, Haruhiko Sano, Yasushi Kubota, Toshihiko Ando, Keisuke Kidoguchi, Kana Kusaba, Hidekazu Itamura, Hiroto Kojima, Yasushi Kusunoki, Yuki Miyazaki, Kensuke Kojima, Hidenori Tanaka, Hiroh Saji, Koichi Oshima, Shinya Kimura Hiroshi Ureshino, Takero Shindo, Haruhiko Sano, Yasushi Kubota, Toshihiko Ando, Keisuke Kidoguchi, Kana Kusaba, Hidekazu Itamura, Hiroto Kojima, Yasushi Kusunoki, Yuki Miyazaki, Kensuke Kojima, Hidenori Tanaka, Hiroh Saji, Koichi Oshima, Shinya Kimura Hiroshi Ureshino, Takero Shindo, Haruhiko Sano, Yasushi Kubota, Toshihiko Ando, Keisuke Kidoguchi, Kana Kusaba, Hidekazu Itamura, Hiroto Kojima, Yasushi Kusunoki, Yuki Miyazaki, Kensuke Kojima, Hidenori Tanaka, Hiroh Saji, Koichi Oshima, Shinya Kimura Reconstitution of NK cells expressing KIR3DL1 is associated with reduced NK cell activity and relapse of CML after allogeneic hematopoietic stem cell transplantation Reconstitution of NK cells expressing KIR3DL1 is associated with reduced NK cell activity and relapse of CML after allogeneic hematopoietic stem cell transplantation Reconstitution of NK cells expressing KIR3DL1 is associated with reduced NK cell activity and relapse of CML after allogeneic hematopoietic stem cell transplantation International Journal of Hematology, 111, 5, 733-738 International Journal of Hematology, 111, 5, 733-738 International Journal of Hematology, 111, 5, 733-738 2020/05 Refereed Research paper(scientific journal) Disclose to all
Hidekazu Itamura, Takero Shindo, Satoshi Yoshioka, Takayuki Ishikawa, Shinya Kimura Hidekazu Itamura, Takero Shindo, Satoshi Yoshioka, Takayuki Ishikawa, Shinya Kimura Hidekazu Itamura, Takero Shindo, Satoshi Yoshioka, Takayuki Ishikawa, Shinya Kimura Phosphorylated ERK1/2 in CD4 T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation Phosphorylated ERK1/2 in CD4 T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation Phosphorylated ERK1/2 in CD4 T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation Blood Advances, 4, 4, 667-671 Blood Advances, 4, 4, 667-671 Blood Advances, 4, 4, 667-671 2020/02/25 Refereed Research paper(scientific journal) Disclose to all
Hiroshi Ureshino, Takero Shindo, Shinya Kimura Hiroshi Ureshino, Takero Shindo, Shinya Kimura Hiroshi Ureshino, Takero Shindo, Shinya Kimura Role of cancer immunology in chronic myelogenous leukemia Role of cancer immunology in chronic myelogenous leukemia Role of cancer immunology in chronic myelogenous leukemia Leukemia Research, 88, 106273-106273 Leukemia Research, 88, 106273-106273 Leukemia Research, 88, 106273-106273 2020/01 Refereed English Research paper(scientific journal) Disclose to all
Sawada K, Takai A, Yamada T, Araki O, Yamauchi Y, Eso Y, Takahashi K, Shindo T, Sakurai T, Ueda Y, Seno H Sawada K, Takai A, Yamada T, Araki O, Yamauchi Y, Eso Y, Takahashi K, Shindo T, Sakurai T, Ueda Y, Seno H Sawada K, Takai A, Yamada T, Araki O, Yamauchi Y, Eso Y, Takahashi K, Shindo T, Sakurai T, Ueda Y, Seno H Hepatitis-associated Aplastic Anemia With Rapid Progression of Liver Fibrosis Due to Repeated Hepatitis. Hepatitis-associated Aplastic Anemia With Rapid Progression of Liver Fibrosis Due to Repeated Hepatitis. Hepatitis-associated Aplastic Anemia With Rapid Progression of Liver Fibrosis Due to Repeated Hepatitis. Internal Medicine Internal Medicine Internal Medicine 2019/12 Refereed English Research paper(scientific journal) Disclose to all
Okamoto S, Ureshino H, Kidoguchi K, Kusaba K, Kizuka-Sano H, Sano H, Nishioka A, Yamaguchi K, Kamachi K, Itamura H, Yoshimura M, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Kawaguchi A, Sueoka E, Kimura S Okamoto S, Ureshino H, Kidoguchi K, Kusaba K, Kizuka-Sano H, Sano H, Nishioka A, Yamaguchi K, Kamachi K, Itamura H, Yoshimura M, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Kawaguchi A, Sueoka E, Kimura S Okamoto S, Ureshino H, Kidoguchi K, Kusaba K, Kizuka-Sano H, Sano H, Nishioka A, Yamaguchi K, Kamachi K, Itamura H, Yoshimura M, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Kawaguchi A, Sueoka E, Kimura S Clinical impact of the CONUT score in patients with multiple myeloma. Clinical impact of the CONUT score in patients with multiple myeloma. Clinical impact of the CONUT score in patients with multiple myeloma. Annals of hematology Annals of hematology Annals of hematology 2019/11 Refereed Disclose to all
Akihiro Takahagi, Takero Shindo, Toyofumi F. Chen-Yoshikawa, Akihiko Yoshizawa, Fumiaki Gochi, Ei Miyamoto, Masao Saito, Satona Tanaka, Hideki Motoyama, Akihiro Aoyama, Akifumi Takaori-Kondo, Hiroshi Date Akihiro Takahagi, Takero Shindo, Toyofumi F. Chen-Yoshikawa, Akihiko Yoshizawa, Fumiaki Gochi, Ei Miyamoto, Masao Saito, Satona Tanaka, Hideki Motoyama, Akihiro Aoyama, Akifumi Takaori-Kondo, Hiroshi Date Akihiro Takahagi, Takero Shindo, Toyofumi F. Chen-Yoshikawa, Akihiko Yoshizawa, Fumiaki Gochi, Ei Miyamoto, Masao Saito, Satona Tanaka, Hideki Motoyama, Akihiro Aoyama, Akifumi Takaori-Kondo, Hiroshi Date Trametinib Attenuates Delayed Rejection and Preserves Thymic Function in Rat Lung Transplantation Trametinib Attenuates Delayed Rejection and Preserves Thymic Function in Rat Lung Transplantation Trametinib Attenuates Delayed Rejection and Preserves Thymic Function in Rat Lung Transplantation American Journal of Respiratory Cell and Molecular Biology, 61, 3, 355-366 American Journal of Respiratory Cell and Molecular Biology, 61, 3, 355-366 American Journal of Respiratory Cell and Molecular Biology, 61, 3, 355-366 2019/09 Refereed English Research paper(scientific journal) Disclose to all
Ureshino H, Kusaba K, Kidoguchi K, Sano H, Nishioka A, Itamura H, Yoshimura M, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Sueoka E, Kimura S Ureshino H, Kusaba K, Kidoguchi K, Sano H, Nishioka A, Itamura H, Yoshimura M, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Sueoka E, Kimura S Ureshino H, Kusaba K, Kidoguchi K, Sano H, Nishioka A, Itamura H, Yoshimura M, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Sueoka E, Kimura S Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/kymphoma. Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/kymphoma. Clinical impact of the CONUT score and mogamulizumab in adult T cell leukemia/kymphoma. Ann Hematol, 98, 2, 465-471 Ann Hematol, 98, 2, 465-471 Ann Hematol, 98, 2, 465-471 2019/02 Refereed English Research paper(scientific journal) Disclose to all
Kamachi K, Shindo T, Miyahara M, Kitaura K, Akashi M, Shin-I T, Suzuki R, Ohshima K, Kimura S Kamachi K, Shindo T, Miyahara M, Kitaura K, Akashi M, Shin-I T, Suzuki R, Ohshima K, Kimura S Kamachi K, Shindo T, Miyahara M, Kitaura K, Akashi M, Shin-I T, Suzuki R, Ohshima K, Kimura S Epstein-Barr virus-related diffuse large B cell lymphoma in mogamulizumab-treated adult T cell leukemia with incomplete T cell reconstitution. Epstein-Barr virus-related diffuse large B cell lymphoma in mogamulizumab-treated adult T cell leukemia with incomplete T cell reconstitution. Epstein-Barr virus-related diffuse large B cell lymphoma in mogamulizumab-treated adult T cell leukemia with incomplete T cell reconstitution. Int J Hematol, 109, 2, 221-227 Int J Hematol, 109, 2, 221-227 Int J Hematol, 109, 2, 221-227 2019/02 Refereed English Research paper(scientific journal) Disclose to all
Shindo T, Ureshino H, Kojima H, Tanaka H, Kimura S 進藤岳郎, 嬉野博志, 小島裕人, 田中秀則, 木村晋也 Shindo T, Ureshino H, Kojima H, Tanaka H, Kimura S Allelic polymorphism of KIRs in chronic myeloid leukemia 慢性骨髄性白血病におけるKIRアレル多型の臨床的意義 Allelic polymorphism of KIRs in chronic myeloid leukemia MHC, 25, 3, 187-195 MHC, 25, 3, 187-195 MHC, 25, 3, 187-195 2018/12 Refereed Japanese Research paper(scientific journal) Disclose to all
Fukushima N, Tomiyasu S, Uji Y, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Sueoka E, Ichinohe T, Kimura S Fukushima N, Tomiyasu S, Uji Y, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Sueoka E, Ichinohe T, Kimura S Fukushima N, Tomiyasu S, Uji Y, Yokoo M, Shindo T, Kubota Y, Ando T, Kojima K, Sueoka E, Ichinohe T, Kimura S Monitoring of citrulline and diamine oxidase levels as biomarkers for intestinal mucositis during early-phase of hematopoietic cell transplantation. Monitoring of citrulline and diamine oxidase levels as biomarkers for intestinal mucositis during early-phase of hematopoietic cell transplantation. Monitoring of citrulline and diamine oxidase levels as biomarkers for intestinal mucositis during early-phase of hematopoietic cell transplantation. Blood Cell Ther Blood Cell Ther Blood Cell Ther 2018/08 Refereed English Research paper(scientific journal) Disclose to all
Hiroshi Ureshino, Takero Shindo, Hiroto Kojima, Yasushi Kusunoki, Yuki Miyazaki, Hidenori Tanaka, Hiroh Saji, Atsushi Kawaguchi, Shinya Kimura Hiroshi Ureshino, Takero Shindo, Hiroto Kojima, Yasushi Kusunoki, Yuki Miyazaki, Hidenori Tanaka, Hiroh Saji, Atsushi Kawaguchi, Shinya Kimura Hiroshi Ureshino, Takero Shindo, Hiroto Kojima, Yasushi Kusunoki, Yuki Miyazaki, Hidenori Tanaka, Hiroh Saji, Atsushi Kawaguchi, Shinya Kimura Allelic polymorphisms of KIRs and HLAs predict favorable responses to tyrosine kinase inhibitors in CML Allelic polymorphisms of KIRs and HLAs predict favorable responses to tyrosine kinase inhibitors in CML Allelic polymorphisms of KIRs and HLAs predict favorable responses to tyrosine kinase inhibitors in CML Cancer Immunology Research, 6, 6, 745-754 Cancer Immunology Research, 6, 6, 745-754 Cancer Immunology Research, 6, 6, 745-754 2018/06/01 Refereed English Research paper(scientific journal) Disclose to all
Fuji S, Utsunomiya A, Inoue Y, Miyagi T, Owatari S, Sawayama Y, Moriuchi Y, Choi I, Shindo T, Yoshida S, Yamasaki S, Yamaguchi T, Fukuda T Fuji S, Utsunomiya A, Inoue Y, Miyagi T, Owatari S, Sawayama Y, Moriuchi Y, Choi I, Shindo T, Yoshida S, Yamasaki S, Yamaguchi T, Fukuda T Fuji S, Utsunomiya A, Inoue Y, Miyagi T, Owatari S, Sawayama Y, Moriuchi Y, Choi I, Shindo T, Yoshida S, Yamasaki S, Yamaguchi T, Fukuda T Outcome of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation. Outcome of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation. Outcome of patients with relapsed aggressive adult T-cell leukemia-lymphoma: clinical effectiveness of anti-CCR4 antibody and allogeneic hematopoietic stem cell transplantation. Haematologica, 103, 5, e211-e214 Haematologica, 103, 5, e211-e214 Haematologica, 103, 5, e211-e214 2018/05 Refereed English Research paper(scientific journal) Disclose to all
Sumie Fujii, Yasuo Miura, Aya Fujishiro, Takero Shindo, Yutaka Shimazu, Hideyo Hirai, Hidetoshi Tahara, Akifumi Takaori-Kondo, Tatsuo Ichinohe, Taira Maekawa Fujii S, Miura Y, Fujishiro A, Shindo T, Shimazu Y, Hirai H, Tahara H, Takaori-Kondo A, Ichinohe T, Maekawa T Sumie Fujii, Yasuo Miura, Aya Fujishiro, Takero Shindo, Yutaka Shimazu, Hideyo Hirai, Hidetoshi Tahara, Akifumi Takaori-Kondo, Tatsuo Ichinohe, Taira Maekawa Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations GVHD amelioration by human bone marrow mesenchymal stromal/stem cell-derived extracellular vesicles is associated with peripheral preservation of naïve T cell populations. Graft-Versus-Host Disease Amelioration by Human Bone Marrow Mesenchymal Stromal/Stem Cell-Derived Extracellular Vesicles Is Associated with Peripheral Preservation of Naive T Cell Populations Stem Cells, 36, 3, 434-445 Stem Cells, 36, 3, 434-445 Stem Cells, 36, 3, 434-445 2018/03 Refereed English Research paper(scientific journal) Disclose to all
Shindo T, Kitaura K, Ureshino H, Kamachi K, Miyahara M, Doi K, Watanabe T, Sueoka E, Shin-I T, Suzuki R, Kimura S Shindo T, Kitaura K, Ureshino H, Kamachi K, Miyahara M, Doi K, Watanabe T, Sueoka E, Shin-I T, Suzuki R, Kimura S Shindo T, Kitaura K, Ureshino H, Kamachi K, Miyahara M, Doi K, Watanabe T, Sueoka E, Shin-I T, Suzuki R, Kimura S Deep sequencing of the T cell receptor visualizes reconstitution of T cell immunity in mogamulizumab-treated adult T cell leukemia. Deep sequencing of the T cell receptor visualizes reconstitution of T cell immunity in mogamulizumab-treated adult T cell leukemia. Deep sequencing of the T cell receptor visualizes reconstitution of T cell immunity in mogamulizumab-treated adult T cell leukemia. Oncoimmunol, 7, 3, e1405204 Oncoimmunol, 7, 3, e1405204 Oncoimmunol, 7, 3, e1405204 2018/03 Refereed English Research paper(scientific journal) Disclose to all
Hiroshi Ureshino, Toshihiko Ando, Haruna Kizuka, Kana Kusaba, Haruhiko Sano, Atsujiro Nishioka, Hidekazu Itamura, Takero Shindo, Yasushi Kubota, Kensuke Kojima, Shinya Kimura Hiroshi Ureshino, Toshihiko Ando, Haruna Kizuka, Kana Kusaba, Haruhiko Sano, Atsujiro Nishioka, Hidekazu Itamura, Takero Shindo, Yasushi Kubota, Kensuke Kojima, Shinya Kimura Hiroshi Ureshino, Toshihiko Ando, Haruna Kizuka, Kana Kusaba, Haruhiko Sano, Atsujiro Nishioka, Hidekazu Itamura, Takero Shindo, Yasushi Kubota, Kensuke Kojima, Shinya Kimura Tocilizumab for severe cytokine-release syndrome after haploidentical donor transplantation in a patient with refractory Epstein-Barr virus-positive diffuse large B-cell lymphoma Tocilizumab for severe cytokine-release syndrome after haploidentical donor transplantation in a patient with refractory Epstein-Barr virus-positive diffuse large B-cell lymphoma Tocilizumab for severe cytokine-release syndrome after haploidentical donor transplantation in a patient with refractory Epstein-Barr virus-positive diffuse large B-cell lymphoma Hematological Oncology, 36, 1, 324-327 Hematological Oncology, 36, 1, 324-327 Hematological Oncology, 36, 1, 324-327 2018/02/01 Refereed English Research paper(scientific journal) Disclose to all
Hiroaki Kitamura, Yasushi Kubota, Kyosuke Yamaguchi, Kazuharu Kamachi, Atsujiro Nishioka, Masako Yokoo, Takero Shindo, Toshihiko Ando, Kensuke Kojima, Shinya Kimura Hiroaki Kitamura, Yasushi Kubota, Kyosuke Yamaguchi, Kazuharu Kamachi, Atsujiro Nishioka, Masako Yokoo, Takero Shindo, Toshihiko Ando, Kensuke Kojima, Shinya Kimura Hiroaki Kitamura, Yasushi Kubota, Kyosuke Yamaguchi, Kazuharu Kamachi, Atsujiro Nishioka, Masako Yokoo, Takero Shindo, Toshihiko Ando, Kensuke Kojima, Shinya Kimura Successful autologous hematopoietic stem cell transplantation followed by bortezomib maintenance in a patient with relapsed CD138-low multiple solitary plasmacytomas harboring a 17p deletion Successful autologous hematopoietic stem cell transplantation followed by bortezomib maintenance in a patient with relapsed CD138-low multiple solitary plasmacytomas harboring a 17p deletion Successful autologous hematopoietic stem cell transplantation followed by bortezomib maintenance in a patient with relapsed CD138-low multiple solitary plasmacytomas harboring a 17p deletion Internal Medicine, 57, 6, 855-860 Internal Medicine, 57, 6, 855-860 Internal Medicine, 57, 6, 855-860 2018 Refereed English Research paper(scientific journal) Disclose to all
Keita Kai, Futa Koga, Norimasa Araki, Takero Shindo, Yuichiro Eguchi, Shuji Toda, Shinichi Aishima Keita Kai, Futa Koga, Norimasa Araki, Takero Shindo, Yuichiro Eguchi, Shuji Toda, Shinichi Aishima Keita Kai, Futa Koga, Norimasa Araki, Takero Shindo, Yuichiro Eguchi, Shuji Toda, Shinichi Aishima Autopsy case of systemic EBV-positive T-cell lymphoma of childhood with marked hepatomegaly in a middle-aged man Autopsy case of systemic EBV-positive T-cell lymphoma of childhood with marked hepatomegaly in a middle-aged man Autopsy case of systemic EBV-positive T-cell lymphoma of childhood with marked hepatomegaly in a middle-aged man PATHOLOGY INTERNATIONAL, 67, 8, 431-433 PATHOLOGY INTERNATIONAL, 67, 8, 431-433 PATHOLOGY INTERNATIONAL, 67, 8, 431-433 2017/08 Refereed English Research paper(scientific journal) Disclose to all
Hidekazu Itamura, Yasushi Kubota, Takero Shindo, Toshihiko Ando, Kensuke Kojima, Shinya Kimura Hidekazu Itamura, Yasushi Kubota, Takero Shindo, Toshihiko Ando, Kensuke Kojima, Shinya Kimura Hidekazu Itamura, Yasushi Kubota, Takero Shindo, Toshihiko Ando, Kensuke Kojima, Shinya Kimura Elderly Patients With Chronic Myeloid Leukemia Benefit From a Dasatinib Dose as Low as 20 mg Elderly Patients With Chronic Myeloid Leukemia Benefit From a Dasatinib Dose as Low as 20 mg Elderly Patients With Chronic Myeloid Leukemia Benefit From a Dasatinib Dose as Low as 20 mg CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 17, 6, 370-374 CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 17, 6, 370-374 CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 17, 6, 370-374 2017/06 Refereed English Research paper(scientific journal) Disclose to all
Hiroshi Ureshino, Haruna Kizuka, Kana Kusaba, Haruhiko Sano, Atsujiro Nishioka, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Kensuke Kojima, Shinya Kimura Hiroshi Ureshino, Haruna Kizuka, Kana Kusaba, Haruhiko Sano, Atsujiro Nishioka, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Kensuke Kojima, Shinya Kimura Hiroshi Ureshino, Haruna Kizuka, Kana Kusaba, Haruhiko Sano, Atsujiro Nishioka, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Kensuke Kojima, Shinya Kimura 5q-syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10) 5q-syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10) 5q-syndrome-like features as the first manifestation of myelodysplastic syndrome in a patient with an unbalanced whole-arm translocation der(5;19)(p10;q10) INTERNATIONAL JOURNAL OF HEMATOLOGY, 105, 5, 692-696 INTERNATIONAL JOURNAL OF HEMATOLOGY, 105, 5, 692-696 INTERNATIONAL JOURNAL OF HEMATOLOGY, 105, 5, 692-696 2017/05 Refereed English Research paper(scientific journal) Disclose to all
Ureshino H, Shindo T, Tanaka H, Kimura S Ureshino H, Shindo T, Tanaka H, Kimura S Ureshino H, Shindo T, Tanaka H, Kimura S Chronic myelogenous leukemia and NK cell immunity. Chronic myelogenous leukemia and NK cell immunity. Chronic myelogenous leukemia and NK cell immunity. Rinsho Ketsueki, 58, 4, 381-388 Rinsho Ketsueki, 58, 4, 381-388 Rinsho Ketsueki, 58, 4, 381-388 2017/04 Refereed Japanese Research paper(scientific journal) Disclose to all
Takashi Akutagawa, Takero Shindo, Kohei Yamanouchi, Masaki Hayakawa, Hiroshi Ureshino, Nanae Tsuruoka, Yasuhisa Sakata, Ryo Shimoda, Ryo Noguchi, Kojiro Furukawa, Shigeki Morita, Ryuichi Iwakiri, Shinya Kimura, Masanori Matsumoto, Kazuma Fujimoto Takashi Akutagawa, Takero Shindo, Kohei Yamanouchi, Masaki Hayakawa, Hiroshi Ureshino, Nanae Tsuruoka, Yasuhisa Sakata, Ryo Shimoda, Ryo Noguchi, Kojiro Furukawa, Shigeki Morita, Ryuichi Iwakiri, Shinya Kimura, Masanori Matsumoto, Kazuma Fujimoto Takashi Akutagawa, Takero Shindo, Kohei Yamanouchi, Masaki Hayakawa, Hiroshi Ureshino, Nanae Tsuruoka, Yasuhisa Sakata, Ryo Shimoda, Ryo Noguchi, Kojiro Furukawa, Shigeki Morita, Ryuichi Iwakiri, Shinya Kimura, Masanori Matsumoto, Kazuma Fujimoto Persistent Gastrointestinal Angiodysplasia in Heyde's Syndrome after Aortic Valve Replacement Persistent Gastrointestinal Angiodysplasia in Heyde's Syndrome after Aortic Valve Replacement Persistent Gastrointestinal Angiodysplasia in Heyde's Syndrome after Aortic Valve Replacement INTERNAL MEDICINE, 56, 18, 2431-2433 INTERNAL MEDICINE, 56, 18, 2431-2433 INTERNAL MEDICINE, 56, 18, 2431-2433 2017 Refereed English Research paper(scientific journal) Disclose to all
進藤 岳郎 進藤 岳郎 成人T細胞白血病(ATL)の診断と治療 成人T細胞白血病(ATL)の診断と治療 ライフライン21, 23 ライフライン21, 23 , 23 2016/10 Japanese Thesis(Other) Disclose to all
Hiroshi Ureshino, Takero Shindo, Hiroyoshi Nishikawa, Nobukazu Watanabe, Eri Watanabe, Natsuko Satoh, Kazutaka Kitaura, Hiroaki Kitamura, Kazuko Doi, Kotaro Nagase, Hiromi Kimura, Makoto Samukawa, Susumu Kusunoki, Masaharu Miyahara, Tadasu Shin-, Ryuji Suzuki, Shimon Sakaguchi, Shinya Kimura Hiroshi Ureshino, Takero Shindo, Hiroyoshi Nishikawa, Nobukazu Watanabe, Eri Watanabe, Natsuko Satoh, Kazutaka Kitaura, Hiroaki Kitamura, Kazuko Doi, Kotaro Nagase, Hiromi Kimura, Makoto Samukawa, Susumu Kusunoki, Masaharu Miyahara, Tadasu Shin-, Ryuji Suzuki, Shimon Sakaguchi, Shinya Kimura Hiroshi Ureshino, Takero Shindo, Hiroyoshi Nishikawa, Nobukazu Watanabe, Eri Watanabe, Natsuko Satoh, Kazutaka Kitaura, Hiroaki Kitamura, Kazuko Doi, Kotaro Nagase, Hiromi Kimura, Makoto Samukawa, Susumu Kusunoki, Masaharu Miyahara, Tadasu Shin-, Ryuji Suzuki, Shimon Sakaguchi, Shinya Kimura Effector Regulatory T Cells Reflect the Equilibrium between Antitumor Immunity and Autoimmunity in Adult T-cell Leukemia Effector Regulatory T Cells Reflect the Equilibrium between Antitumor Immunity and Autoimmunity in Adult T-cell Leukemia Effector Regulatory T Cells Reflect the Equilibrium between Antitumor Immunity and Autoimmunity in Adult T-cell Leukemia CANCER IMMUNOLOGY RESEARCH, 4, 8, 644-649 CANCER IMMUNOLOGY RESEARCH, 4, 8, 644-649 CANCER IMMUNOLOGY RESEARCH, 4, 8, 644-649 2016/08 Refereed English Research paper(scientific journal) Disclose to all
Itamura H, Shindo T, Tawara I, Kubota Y, Kariya R, Okada S, Komanduri KV, Kimura S Itamura H, Shindo T, Tawara I, Kubota Y, Kariya R, Okada S, Komanduri KV, Kimura S Itamura H, Shindo T, Tawara I, Kubota Y, Kariya R, Okada S, Komanduri KV, Kimura S The MEK inhibitor trametinib separates murine Graft-versus-Host Disease from Graft-versus-Tumor Effects. The MEK inhibitor trametinib separates murine Graft-versus-Host Disease from Graft-versus-Tumor Effects. The MEK inhibitor trametinib separates murine Graft-versus-Host Disease from Graft-versus-Tumor Effects. JCI Insight, 1, 10, e86331 JCI Insight, 1, 10, e86331 JCI Insight, 1, 10, e86331 2016/07 Refereed English Research paper(scientific journal) Disclose to all
Hiroaki Kitamura, Takero Shindo, Yusuke Yakushiji, Mari Yoshihara, Makoto Eriguchi, Yasushi Kubota, Tomoyuki Noguchi, Shinya Kimura Hiroaki Kitamura, Takero Shindo, Yusuke Yakushiji, Mari Yoshihara, Makoto Eriguchi, Yasushi Kubota, Tomoyuki Noguchi, Shinya Kimura Hiroaki Kitamura, Takero Shindo, Yusuke Yakushiji, Mari Yoshihara, Makoto Eriguchi, Yasushi Kubota, Tomoyuki Noguchi, Shinya Kimura Domino-Style Cerebral Bleeding in a Patient With Immune Thrombocytopenic Purpura Domino-Style Cerebral Bleeding in a Patient With Immune Thrombocytopenic Purpura Domino-Style Cerebral Bleeding in a Patient With Immune Thrombocytopenic Purpura JAMA NEUROLOGY, 73, 4, 474-475 JAMA NEUROLOGY, 73, 4, 474-475 JAMA NEUROLOGY, 73, 4, 474-475 2016/04 Refereed English Research paper(scientific journal) Disclose to all
Fuji S, Shindo T Fuji S, Shindo T Fuji S, Shindo T Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation in adult T-cell leukemia. Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation in adult T-cell leukemia. Friend or foe? Mogamulizumab in allogeneic hematopoietic stem cell transplantation in adult T-cell leukemia. Stem Cell Investig, 3, 70 Stem Cell Investig, 3, 70 Stem Cell Investig, 3, 70 2016/03 Refereed English Research paper(scientific journal) Disclose to all
Hiroshi Ureshino, Atsujiro Nishioka, Kensuke Kojima, Motoaki Suzuki, Haruna Kizuka, Haruhiko Sano, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Shinya Kimura Hiroshi Ureshino, Atsujiro Nishioka, Kensuke Kojima, Motoaki Suzuki, Haruna Kizuka, Haruhiko Sano, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Shinya Kimura Hiroshi Ureshino, Atsujiro Nishioka, Kensuke Kojima, Motoaki Suzuki, Haruna Kizuka, Haruhiko Sano, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Shinya Kimura Rituximab-induced Acute Thrombocytopenia in High Tumor Burden Follicular Lymphoma Rituximab-induced Acute Thrombocytopenia in High Tumor Burden Follicular Lymphoma Rituximab-induced Acute Thrombocytopenia in High Tumor Burden Follicular Lymphoma INTERNAL MEDICINE, 55, 15, 2061-2064 INTERNAL MEDICINE, 55, 15, 2061-2064 INTERNAL MEDICINE, 55, 15, 2061-2064 2016 Refereed English Research paper(scientific journal) Disclose to all
Hiroshi Ureshino, Atsujiro Nishioka, Kensuke Kojima, Haruna Kizuka, Haruhiko Sano, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Shinya Kimura Hiroshi Ureshino, Atsujiro Nishioka, Kensuke Kojima, Haruna Kizuka, Haruhiko Sano, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Shinya Kimura Hiroshi Ureshino, Atsujiro Nishioka, Kensuke Kojima, Haruna Kizuka, Haruhiko Sano, Takero Shindo, Yasushi Kubota, Toshihiko Ando, Shinya Kimura Subdural Hematoma Associated with Dasatinib and Intrathecal Methotrexate Treatment in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Subdural Hematoma Associated with Dasatinib and Intrathecal Methotrexate Treatment in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia Subdural Hematoma Associated with Dasatinib and Intrathecal Methotrexate Treatment in Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia INTERNAL MEDICINE, 55, 18, 2703-2706 INTERNAL MEDICINE, 55, 18, 2703-2706 INTERNAL MEDICINE, 55, 18, 2703-2706 2016 Refereed English Research paper(scientific journal) Disclose to all
Kazuharu Kamachi, Noriyasu Fukushima, Toshihiko Ando, Ken-ichi Sato, Koichi Ohshima, Masako Yokoo, Takero Shindo, Yasushi Kubota, Kensuke Kojima, Shinya Kimura Kazuharu Kamachi, Noriyasu Fukushima, Toshihiko Ando, Ken-ichi Sato, Koichi Ohshima, Masako Yokoo, Takero Shindo, Yasushi Kubota, Kensuke Kojima, Shinya Kimura Kazuharu Kamachi, Noriyasu Fukushima, Toshihiko Ando, Ken-ichi Sato, Koichi Ohshima, Masako Yokoo, Takero Shindo, Yasushi Kubota, Kensuke Kojima, Shinya Kimura Coexistence of ALK-anaplastic large cell lymphoma and CD4+T cell large granular lymphocytic leukemia Coexistence of ALK-anaplastic large cell lymphoma and CD4+T cell large granular lymphocytic leukemia Coexistence of ALK-anaplastic large cell lymphoma and CD4+T cell large granular lymphocytic leukemia ANNALS OF HEMATOLOGY, 94, 3, 539-540 ANNALS OF HEMATOLOGY, 94, 3, 539-540 ANNALS OF HEMATOLOGY, 94, 3, 539-540 2015/03 Refereed English Research paper(scientific journal) Disclose to all
Shindo T, Kimura S 進藤岳郎, 木村晋也 Shindo T, Kimura S Immune defects in multiple myeloma. 多発性骨髄腫における免疫異常 Immune defects in multiple myeloma. Nippon Rinsho, 73, 1, 52-56 日本臨床, 73, 1, 52-56 Nippon Rinsho, 73, 1, 52-56 2015/01 Refereed Japanese Research paper(scientific journal) Disclose to all
Shigeo Fuji, Takero Shindo Shigeo Fuji, Takero Shindo Shigeo Fuji, Takero Shindo T-Cell Characterization Using Multicolor Flow Cytometry After Allogeneic Hematopoietic Stem-Cell Transplantation T-Cell Characterization Using Multicolor Flow Cytometry After Allogeneic Hematopoietic Stem-Cell Transplantation T-Cell Characterization Using Multicolor Flow Cytometry After Allogeneic Hematopoietic Stem-Cell Transplantation JOURNAL OF CLINICAL ONCOLOGY, 32, 17, 1859-1860 JOURNAL OF CLINICAL ONCOLOGY, 32, 17, 1859-1860 JOURNAL OF CLINICAL ONCOLOGY, 32, 17, 1859-1860 2014/06 Refereed English Research paper(scientific journal) Disclose to all
Mari Yoshihara, Hidekazu Itamura, Noriyasu Fukushima, Manabu Itoh, Kojiro Furukawa, Daisuke Nagatomo, Kazuharu Kamachi, Hiroaki Kitamura, Takero Shindo, Yasushi Kubota, Eisaburo Sueoka, Shigeki Morita, Tatsuo Ichinohe, Shinya Kimura Mari Yoshihara, Hidekazu Itamura, Noriyasu Fukushima, Manabu Itoh, Kojiro Furukawa, Daisuke Nagatomo, Kazuharu Kamachi, Hiroaki Kitamura, Takero Shindo, Yasushi Kubota, Eisaburo Sueoka, Shigeki Morita, Tatsuo Ichinohe, Shinya Kimura Mari Yoshihara, Hidekazu Itamura, Noriyasu Fukushima, Manabu Itoh, Kojiro Furukawa, Daisuke Nagatomo, Kazuharu Kamachi, Hiroaki Kitamura, Takero Shindo, Yasushi Kubota, Eisaburo Sueoka, Shigeki Morita, Tatsuo Ichinohe, Shinya Kimura Therapeutic management in cardiac lymphoma Therapeutic management in cardiac lymphoma Therapeutic management in cardiac lymphoma LEUKEMIA & LYMPHOMA, 55, 5, 1215-1217 LEUKEMIA & LYMPHOMA, 55, 5, 1215-1217 LEUKEMIA & LYMPHOMA, 55, 5, 1215-1217 2014/05 Refereed English Research paper(scientific journal) Disclose to all
末岡榮三朗, 山田尚友, 山田麻里江, 久保田 寧, 吉村麻里子, 板村英和, 出 勝, 横尾眞子, 吉原麻里, 蒲池和晴, 北村浩晃, 進藤岳郎, 安藤寿彦, 小島研介, 東谷孝徳, 木村晋也 末岡榮三朗, 山田尚友, 山田麻里江, 久保田 寧, 吉村麻里子, 板村英和, 出 勝, 横尾眞子, 吉原麻里, 蒲池和晴, 北村浩晃, 進藤岳郎, 安藤寿彦, 小島研介, 東谷孝徳, 木村晋也 電子カルテと輸血管理システムの連携による輸血後鉄過剰症モニタリングの運用とその課題 電子カルテと輸血管理システムの連携による輸血後鉄過剰症モニタリングの運用とその課題 電子カルテと輸血管理システムの連携による輸血後鉄過剰症モニタリングの運用とその課題 , 60, 1 , 60, 1 , 60, 1 2014/01 Refereed Disclose to all
Shindo T, Kim TK, Benjamin CL, Wieder ED, Levy RB, Komanduri KV Shindo T, Kim TK, Benjamin CL, Wieder ED, Levy RB, Komanduri KV Shindo T, Kim TK, Benjamin CL, Wieder ED, Levy RB, Komanduri KV MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent manner. MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent manner. MEK inhibitors selectively suppress alloreactivity and graft-versus-host disease in a memory stage-dependent manner. Blood, 121, 23, 4617-4626 Blood, 121, 23, 4617-4626 Blood, 121, 23, 4617-4626 2013/06 Refereed English Research paper(scientific journal) Disclose to all
進藤 岳郎, 木村晋也 進藤 岳郎, 木村晋也 慢性骨髄性白血病(CML)治療 〜残された課題〜 慢性骨髄性白血病(CML)治療 〜残された課題〜 血液フロンティア, 23, 2, 73-80 血液フロンティア, 23, 2, 73-80 , 23, 2, 73-80 2013/02 Refereed Japanese Thesis(Other) Disclose to all
Sueoka E, Yamada N, Yamada M, Kubota Y, Urata C, Yoshimura M, Itamura H, Hisatomi T, Fukushima N, Ide M, Yokoo M, Yoshihara M, Kitamura H, Shindo T, Ichinohe T, Higashitani T, Kimura S 末岡榮三朗, 山田尚友, 山田麻里江, 久保田 寧, 浦田千紗子, 吉村麻里子, 板村英和, 久富崇, 福島伯泰, 出勝, 横尾眞子, 吉原麻里, 蒲池和晴, 北村浩晃, 進藤岳郎, 一戸辰夫, 東谷孝徳, 木村晋也 Sueoka E, Yamada N, Yamada M, Kubota Y, Urata C, Yoshimura M, Itamura H, Hisatomi T, Fukushima N, Ide M, Yokoo M, Yoshihara M, Kitamura H, Shindo T, Ichinohe T, Higashitani T, Kimura S Management of transfusional iron overload. 輸血後鉄過剰症の現状と問題点 Management of transfusional iron overload. Japanese J of Transfusion and Cell Therapy, 59, 1, 73-78 日本輸血細胞治療学会誌, 59, 1, 73-78 Japanese J of Transfusion and Cell Therapy, 59, 1, 73-78 2013/01 Refereed Japanese Research paper(scientific journal) Disclose to all
Takero Shindo, Takayuki Ishikawa, Akiko Fukunaga, Toshiyuki Hori, Takashi Uchiyama Takero Shindo, Takayuki Ishikawa, Akiko Fukunaga, Toshiyuki Hori, Takashi Uchiyama Takero Shindo, Takayuki Ishikawa, Akiko Fukunaga, Toshiyuki Hori, Takashi Uchiyama Growth and differentiation advantages of CD4(+)OX40(+) T cells from allogeneic hematopoietic stem cell transplantation recipients Growth and differentiation advantages of CD4(+)OX40(+) T cells from allogeneic hematopoietic stem cell transplantation recipients Growth and differentiation advantages of CD4(+)OX40(+) T cells from allogeneic hematopoietic stem cell transplantation recipients BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 14, 3, 268-281 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 14, 3, 268-281 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 14, 3, 268-281 2008/03 Refereed English Research paper(scientific journal) Disclose to all
Akiko Fukunaga, Takayuki Ishikawa, Masako Kishihata, Takero Shindo, Toshiyuki Hori, Takashi Uchiyama Akiko Fukunaga, Takayuki Ishikawa, Masako Kishihata, Takero Shindo, Toshiyuki Hori, Takashi Uchiyama Akiko Fukunaga, Takayuki Ishikawa, Masako Kishihata, Takero Shindo, Toshiyuki Hori, Takashi Uchiyama Altered homeostasis of CD4(+) memory T cells in allogeneic hematopoietic stem cell transplant recipients: Chronic graft-versus-host disease enhances T cell differentiation and exhausts central memory T cell pool Altered homeostasis of CD4(+) memory T cells in allogeneic hematopoietic stem cell transplant recipients: Chronic graft-versus-host disease enhances T cell differentiation and exhausts central memory T cell pool Altered homeostasis of CD4(+) memory T cells in allogeneic hematopoietic stem cell transplant recipients: Chronic graft-versus-host disease enhances T cell differentiation and exhausts central memory T cell pool BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 13, 10, 1176-1184 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 13, 10, 1176-1184 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 13, 10, 1176-1184 2007/10 Refereed English Research paper(scientific journal) Disclose to all
Shindo T, Yumoto Y, Yoshida M, Okuda T 進藤岳郎, 湯本義一, 吉田道明, 奥田哲也 Shindo T, Yumoto Y, Yoshida M, Okuda T Nonsecretory primary plasma cell leukemia successfully treated with VAD and MP therapy. VAD療法およびMP療法が奏効した非分泌型形質細胞白血病 Nonsecretory primary plasma cell leukemia successfully treated with VAD and MP therapy. Rinsho Ketsueki, 43, 2, 107-111 臨床血液, 43, 2, 107-111 Rinsho Ketsueki, 43, 2, 107-111 2002/02 Refereed Japanese Research paper(scientific journal) Disclose to all

  • <<
  • >>
Title language:
Misc
Author Author(Japanese) Author(English) Title Title(Japanese) Title(English) Bibliography Bibliography(Japanese) Bibliography(English) Publication date Refereed paper Language Publishing type Disclose
和田 典也, 中村 桃子, 近藤 忠一, 進藤 岳郎, 北脇 年雄, 菱澤 方勝, 山下 浩平, 高折 晃史, 井澤 和司, 八角 高裕 和田 典也, 中村 桃子, 近藤 忠一, 進藤 岳郎, 北脇 年雄, 菱澤 方勝, 山下 浩平, 高折 晃史, 井澤 和司, 八角 高裕 X連鎖重症複合免疫不全症に合併したホジキン様EBV関連リンパ増殖性疾患の1例 X連鎖重症複合免疫不全症に合併したホジキン様EBV関連リンパ増殖性疾患の1例 臨床血液, 61, 2, 197-197 臨床血液, 61, 2, 197-197 , 61, 2, 197-197 2020/02 Japanese Disclose to all
多田 誠一郎, 穴澤 貴行, 進藤 岳郎, 山根 佳, 井ノ口 健太, 増井 俊彦, 海道 利実, 岡島 英明, 角 昭一郎, 上本 伸二 多田 誠一郎, 穴澤 貴行, 進藤 岳郎, 山根 佳, 井ノ口 健太, 増井 俊彦, 海道 利実, 岡島 英明, 角 昭一郎, 上本 伸二 多田 誠一郎, 穴澤 貴行, 進藤 岳郎, 山根 佳, 井ノ口 健太, 増井 俊彦, 海道 利実, 岡島 英明, 角 昭一郎, 上本 伸二 MEK阻害剤トラメチニブはMHC不適合マウス膵島移植で膵島毒性を示すことなく拒絶反応を抑制する MEK阻害剤トラメチニブはMHC不適合マウス膵島移植で膵島毒性を示すことなく拒絶反応を抑制する MEK阻害剤トラメチニブはMHC不適合マウス膵島移植で膵島毒性を示すことなく拒絶反応を抑制する MHC: Major Histocompatibility Complex, 26, 2Suppl., 112-112 MHC: Major Histocompatibility Complex, 26, 2Suppl., 112-112 MHC: Major Histocompatibility Complex, 26, 2Suppl., 112-112 2019/09 Japanese Disclose to all
多田 誠一郎, 穴澤 貴行, 進藤 岳郎, 山根 佳, 井ノ口 健太, 増井 俊彦, 海道 利実, 岡島 英明, 角 昭一郎, 上本 伸二 多田 誠一郎, 穴澤 貴行, 進藤 岳郎, 山根 佳, 井ノ口 健太, 増井 俊彦, 海道 利実, 岡島 英明, 角 昭一郎, 上本 伸二 多田 誠一郎, 穴澤 貴行, 進藤 岳郎, 山根 佳, 井ノ口 健太, 増井 俊彦, 海道 利実, 岡島 英明, 角 昭一郎, 上本 伸二 膵島移植における新規免疫抑制療法 MEK阻害剤の応用 膵島移植における新規免疫抑制療法 MEK阻害剤の応用 膵島移植における新規免疫抑制療法 MEK阻害剤の応用 MHC: Major Histocompatibility Complex, 26, 1, 53-53 MHC: Major Histocompatibility Complex, 26, 1, 53-53 MHC: Major Histocompatibility Complex, 26, 1, 53-53 2019/04 Japanese Disclose to all
嬉野博志, 吉村麻里子, 横尾眞子, 進藤岳郎, 久保田寧, 安藤寿彦, 小島研介, 末岡榮三朗, 木村晋也 嬉野博志, 吉村麻里子, 横尾眞子, 進藤岳郎, 久保田寧, 安藤寿彦, 小島研介, 末岡榮三朗, 木村晋也 嬉野博志, 吉村麻里子, 横尾眞子, 進藤岳郎, 久保田寧, 安藤寿彦, 小島研介, 末岡榮三朗, 木村晋也 成人T細胞白血病におけるCONUTスコア及びモガムリズマブが与える臨床的影響 成人T細胞白血病におけるCONUTスコア及びモガムリズマブが与える臨床的影響 成人T細胞白血病におけるCONUTスコア及びモガムリズマブが与える臨床的影響 日本内科学会雑誌, 108, 203 日本内科学会雑誌, 108, 203 日本内科学会雑誌, 108, 203 2019/02/28 Japanese Disclose to all
藤井紀恵, 三浦康生, 藤城 綾, 進藤岳郎, 島津 裕, 平位秀世, 高折晃史, 一戸辰夫, 前川 平 藤井紀恵, 三浦康生, 藤城 綾, 進藤岳郎, 島津 裕, 平位秀世, 高折晃史, 一戸辰夫, 前川 平 ヒト骨髄間葉系幹細胞由来細胞外小胞はナイーヴ制御性T細胞を保持し、急性移植片対宿病を緩和する ヒト骨髄間葉系幹細胞由来細胞外小胞はナイーヴ制御性T細胞を保持し、急性移植片対宿病を緩和する 第40回日本造血細胞移植学会総会 第40回日本造血細胞移植学会総会 2018/02 Disclose to all
進藤岳郎, 嬉野博志, 小島裕人, 楠木靖史, 宮崎有紀, 田中秀則, 佐治博夫, 川口淳, 木村晋也 進藤岳郎, 嬉野博志, 小島裕人, 楠木靖史, 宮崎有紀, 田中秀則, 佐治博夫, 川口淳, 木村晋也 進藤岳郎, 嬉野博志, 小島裕人, 楠木靖史, 宮崎有紀, 田中秀則, 佐治博夫, 川口淳, 木村晋也 慢性骨髄性白血病におけるKIRとHLAのアリル多型はチロシンキナーゼ阻害剤の治療効果と相関する 慢性骨髄性白血病におけるKIRとHLAのアリル多型はチロシンキナーゼ阻害剤の治療効果と相関する 慢性骨髄性白血病におけるKIRとHLAのアリル多型はチロシンキナーゼ阻害剤の治療効果と相関する MHC (Web), 24, 2 Suppl, 65 MHC (Web), 24, 2 Suppl, 65 MHC (Web), 24, 2 Suppl, 65 2017/10/18 Japanese Disclose to all
佐野晴彦, 安藤寿彦, 久保田寧, 久保田寧, 西岡敦二郎, 木塚遥菜, 嬉野博志, 進藤岳郎, 小島研介, 大島孝一, 木村晋也 佐野晴彦, 安藤寿彦, 久保田寧, 久保田寧, 西岡敦二郎, 木塚遥菜, 嬉野博志, 進藤岳郎, 小島研介, 大島孝一, 木村晋也 佐野晴彦, 安藤寿彦, 久保田寧, 久保田寧, 西岡敦二郎, 木塚遥菜, 嬉野博志, 進藤岳郎, 小島研介, 大島孝一, 木村晋也 脾摘後に自然寛解し2年後に再発したCD5陽性びまん性大細胞型B細胞リンパ腫 脾摘後に自然寛解し2年後に再発したCD5陽性びまん性大細胞型B細胞リンパ腫 脾摘後に自然寛解し2年後に再発したCD5陽性びまん性大細胞型B細胞リンパ腫 臨床血液, 57, 9, 1726 臨床血液, 57, 9, 1726 臨床血液, 57, 9, 1726 2016/09/30 Japanese Disclose to all
西岡敦二郎, 安藤寿彦, 木塚遥菜, 佐野晴彦, 嬉野博志, 進藤岳郎, 久保田寧, 久保田寧, 小島研介, 末岡榮三朗, 末岡榮三朗, 木村晋也 西岡敦二郎, 安藤寿彦, 木塚遥菜, 佐野晴彦, 嬉野博志, 進藤岳郎, 久保田寧, 久保田寧, 小島研介, 末岡榮三朗, 末岡榮三朗, 木村晋也 西岡敦二郎, 安藤寿彦, 木塚遥菜, 佐野晴彦, 嬉野博志, 進藤岳郎, 久保田寧, 久保田寧, 小島研介, 末岡榮三朗, 末岡榮三朗, 木村晋也 alternative donorからの同種移植における移植後早期の臨床的特徴について alternative donorからの同種移植における移植後早期の臨床的特徴について alternative donorからの同種移植における移植後早期の臨床的特徴について 日本造血細胞移植学会総会プログラム・抄録集, 38th, 252 日本造血細胞移植学会総会プログラム・抄録集, 38th, 252 日本造血細胞移植学会総会プログラム・抄録集, 38th, 252 2016/02/10 Japanese Disclose to all
古賀ちひろ, 西岡敦二郎, 嬉野博志, 佐野晴彦, 木塚遥菜, 進藤岳郎, 久保田寧, 安藤寿彦, 小島研介, 木村晋也 古賀ちひろ, 西岡敦二郎, 嬉野博志, 佐野晴彦, 木塚遥菜, 進藤岳郎, 久保田寧, 安藤寿彦, 小島研介, 木村晋也 古賀ちひろ, 西岡敦二郎, 嬉野博志, 佐野晴彦, 木塚遥菜, 進藤岳郎, 久保田寧, 安藤寿彦, 小島研介, 木村晋也 ダサチニブ内服およびメソトレキサート髄注施行後硬膜下血腫を来たしたフィラデルフィア染色体陽性急性リンパ球性白血病(Ph陽性ALL) ダサチニブ内服およびメソトレキサート髄注施行後硬膜下血腫を来たしたフィラデルフィア染色体陽性急性リンパ球性白血病(Ph陽性ALL) ダサチニブ内服およびメソトレキサート髄注施行後硬膜下血腫を来たしたフィラデルフィア染色体陽性急性リンパ球性白血病(Ph陽性ALL) 臨床血液, 57, 6, 797‐798(J‐STAGE) 臨床血液, 57, 6, 797‐798(J‐STAGE) 臨床血液, 57, 6, 797‐798(J‐STAGE) 2016 Japanese Disclose to all
進藤岳郎, 北浦一孝, 長谷川温彦, 渡辺信和, 西川博嘉, 嬉野博志, 蒲池和晴, 宮原正晴, 土井和子, 渡邊達郎, 末岡榮三朗, 新井理, 鈴木隆二, 鈴木隆二, 木村晋也 進藤岳郎, 北浦一孝, 長谷川温彦, 渡辺信和, 西川博嘉, 嬉野博志, 蒲池和晴, 宮原正晴, 土井和子, 渡邊達郎, 末岡榮三朗, 新井理, 鈴木隆二, 鈴木隆二, 木村晋也 進藤岳郎, 北浦一孝, 長谷川温彦, 渡辺信和, 西川博嘉, 嬉野博志, 蒲池和晴, 宮原正晴, 土井和子, 渡邊達郎, 末岡榮三朗, 新井理, 鈴木隆二, 鈴木隆二, 木村晋也 次世代シークエンサーを用いたTCRレパトア解析はモガムリズマブによる細胞性免疫の再構築を可視化する 次世代シークエンサーを用いたTCRレパトア解析はモガムリズマブによる細胞性免疫の再構築を可視化する 次世代シークエンサーを用いたTCRレパトア解析はモガムリズマブによる細胞性免疫の再構築を可視化する 日本HTLV‐1学会学術集会, 3rd, 48 日本HTLV‐1学会学術集会, 3rd, 48 日本HTLV‐1学会学術集会, 3rd, 48 2016 Japanese Disclose to all
進藤岳郎, 楠木靖史, 嬉野博志, 宮原正晴, 渡邉達郎, 末岡榮三朗, 森脇祐司, 吉田真一郎, 一戸辰夫, ESPINOZA Luis J, 高見昭良, 田中秀則, 佐治博夫, 木村晋也 進藤岳郎, 楠木靖史, 嬉野博志, 宮原正晴, 渡邉達郎, 末岡榮三朗, 森脇祐司, 吉田真一郎, 一戸辰夫, ESPINOZA Luis J, 高見昭良, 田中秀則, 佐治博夫, 木村晋也 進藤岳郎, 楠木靖史, 嬉野博志, 宮原正晴, 渡邉達郎, 末岡榮三朗, 森脇祐司, 吉田真一郎, 一戸辰夫, ESPINOZA Luis J, 高見昭良, 田中秀則, 佐治博夫, 木村晋也 成人T細胞白血病に対するモガムリズマブの効果は活性型NK細胞受容体とリガンドのマッチングによって予測できる可能性がある 成人T細胞白血病に対するモガムリズマブの効果は活性型NK細胞受容体とリガンドのマッチングによって予測できる可能性がある 成人T細胞白血病に対するモガムリズマブの効果は活性型NK細胞受容体とリガンドのマッチングによって予測できる可能性がある 日本組織適合性学会大会抄録集, 24th, 89 日本組織適合性学会大会抄録集, 24th, 89 日本組織適合性学会大会抄録集, 24th, 89 2015/08/31 Japanese Disclose to all
板村 英和, 進藤 岳郎, 俵 功, 刈谷 龍昇, 岡田 誠治, 木村 晋也 板村 英和, 進藤 岳郎, 俵 功, 刈谷 龍昇, 岡田 誠治, 木村 晋也 板村 英和, 進藤 岳郎, 俵 功, 刈谷 龍昇, 岡田 誠治, 木村 晋也 MEK阻害剤による移植後GVHDの選択的抑制と感染・腫瘍免疫の温存 MEK阻害剤による移植後GVHDの選択的抑制と感染・腫瘍免疫の温存 MEK阻害剤による移植後GVHDの選択的抑制と感染・腫瘍免疫の温存 先進医薬研究振興財団研究成果報告集, 2014年度, 102-103 先進医薬研究振興財団研究成果報告集, 2014年度, 102-103 先進医薬研究振興財団研究成果報告集, 2014年度, 102-103 2015/03 Japanese Disclose to all
Hidekazu Itamura, Takero Shindo, Isao Tawara, Ryusho Kariya, Seiji Okada, Krishna V. Komanduri, Shinya Kimura Hidekazu Itamura, Takero Shindo, Isao Tawara, Ryusho Kariya, Seiji Okada, Krishna V. Komanduri, Shinya Kimura Hidekazu Itamura, Takero Shindo, Isao Tawara, Ryusho Kariya, Seiji Okada, Krishna V. Komanduri, Shinya Kimura The MEK Inhibitor Trametinib Selectively Suppresses GVHD, While Sparing GVT Effects The MEK Inhibitor Trametinib Selectively Suppresses GVHD, While Sparing GVT Effects The MEK Inhibitor Trametinib Selectively Suppresses GVHD, While Sparing GVT Effects BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 21, 2, S333-S334 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 21, 2, S333-S334 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 21, 2, S333-S334 2015/02 English Research paper, summary (international conference) Disclose to all
進藤岳郎, 楠木靖史, 嬉野博志, 宮原正晴, 渡邉達郎, 末岡榮三朗, 森脇祐司, 吉田真一郎, 一戸辰夫, ESPINOZA Luis J, 高見昭良, 田中秀則, 佐治博夫, 木村晋也 進藤岳郎, 楠木靖史, 嬉野博志, 宮原正晴, 渡邉達郎, 末岡榮三朗, 森脇祐司, 吉田真一郎, 一戸辰夫, ESPINOZA Luis J, 高見昭良, 田中秀則, 佐治博夫, 木村晋也 進藤岳郎, 楠木靖史, 嬉野博志, 宮原正晴, 渡邉達郎, 末岡榮三朗, 森脇祐司, 吉田真一郎, 一戸辰夫, ESPINOZA Luis J, 高見昭良, 田中秀則, 佐治博夫, 木村晋也 成人T細胞白血病に対するモガムリズマブの効果は活性型NK細胞受容体とリガンドのマッチングによって予測できる可能性がある 成人T細胞白血病に対するモガムリズマブの効果は活性型NK細胞受容体とリガンドのマッチングによって予測できる可能性がある 成人T細胞白血病に対するモガムリズマブの効果は活性型NK細胞受容体とリガンドのマッチングによって予測できる可能性がある 日本HTLV‐1学会学術集会, 2nd, 30 日本HTLV‐1学会学術集会, 2nd, 30 日本HTLV‐1学会学術集会, 2nd, 30 2015 Japanese Disclose to all
Eric Wieder, Despina Kolonias, Cara Benjamin, Takero Shindo, Tae Kon Kim, Robert B. Levy, Krishna V. Komanduri Eric Wieder, Despina Kolonias, Cara Benjamin, Takero Shindo, Tae Kon Kim, Robert B. Levy, Krishna V. Komanduri Eric Wieder, Despina Kolonias, Cara Benjamin, Takero Shindo, Tae Kon Kim, Robert B. Levy, Krishna V. Komanduri Trametinib Selectively Inhibits Alloreactivity While Sparing Virus-Specific T Cells Trametinib Selectively Inhibits Alloreactivity While Sparing Virus-Specific T Cells Trametinib Selectively Inhibits Alloreactivity While Sparing Virus-Specific T Cells BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20, 2, S283-S283 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20, 2, S283-S283 BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 20, 2, S283-S283 2014/02 English Research paper, summary (international conference) Disclose to all

  • <<
  • >>
Title language:
Conference Activities & Talks
Title Title(Japanese) Title(English) Conference Conference(Japanese) Conference(English) Promotor Promotor(Japanese) Promotor(English) Date Language Assortment Disclose
Graft-Versus-Host Disease Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm. Graft-Versus-Host Disease Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm. Graft-Versus-Host Disease Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm. The 61st Annual Meeting of the American Society of Hematology (ASH) 第61回米国血液学会議 The 61st Annual Meeting of the American Society of Hematology (ASH) 2019/12/08 English Poster presentation Disclose to all
The MEK inhibitor trametinib enhances diverse T cell reconstitution with suppressing xenogeneic GVHD. MEK阻害剤トラメチニブは異種移植によるGVHDにおけるT細胞免疫の再構築を促進する The MEK inhibitor trametinib enhances diverse T cell reconstitution with suppressing xenogeneic GVHD. The 61st Annual Meeting of the American Society of Hematology (ASH) 第61回米国血液学会議 The 61st Annual Meeting of the American Society of Hematology (ASH) 2019/12/08 English Poster presentation Disclose to all
骨髄炎に続発した髄外腫瘤を伴う急性前骨髄球性白血病 骨髄炎に続発した髄外腫瘤を伴う急性前骨髄球性白血病 第110回近畿血液学地方会 第110回近畿血液学地方会 2019/11/16 Disclose to all
MEK阻害薬トラメチニブは異種移植GVHDを抑制しつつT細胞免疫の再構築を促進する MEK阻害薬トラメチニブは異種移植GVHDを抑制しつつT細胞免疫の再構築を促進する 第81回日本血液学会総会 第81回日本血液学会総会 2019/10/13 Disclose to all
膵島移植におけるMEK阻害剤の可能性. 膵島移植におけるMEK阻害剤の可能性. 第55回日本移植学会総会 第55回日本移植学会総会 2019/10/11 Disclose to all
MEK阻害薬トラメチニブは異種移植においてGVHDを抑制しつつT細胞免疫の再構築を促進する MEK阻害薬トラメチニブは異種移植においてGVHDを抑制しつつT細胞免疫の再構築を促進する 第11回日本血液疾患免疫療法学会学術集会 第11回日本血液疾患免疫療法学会学術集会 2019/10/05 Disclose to all
Allelic polymorphisms of KIRs and HLAs predict favorable responses to tyrosine kinase inhibitors in CML.[Invited] CMLにおけるチロシンキナーゼ阻害剤の治療効果はKIRアレルとHLA多型で予測できる [Invited] Allelic polymorphisms of KIRs and HLAs predict favorable responses to tyrosine kinase inhibitors in CML. [Invited] The 78th Annual Meeting of the Japanese Cancer Association (International Symposium) 第78回日本癌学会学術集会 The 78th Annual Meeting of the Japanese Cancer Association (International Symposium) 2019/09/28 English Symposium workshop panel(nominated) Disclose to all
MEK阻害剤トラメチニブはMHC不適合マウス膵島移植で膵島毒性を示すことなく拒絶反応を抑制する MEK阻害剤トラメチニブはMHC不適合マウス膵島移植で膵島毒性を示すことなく拒絶反応を抑制する 第28回日本組織適合性学会大会 第28回日本組織適合性学会大会 2019/09/23 Disclose to all
Mogamulizumb投与後にもT細胞再構築が得られずEBV関連中枢神経原発B細胞リンパ腫を発症したATL Mogamulizumb投与後にもT細胞再構築が得られずEBV関連中枢神経原発B細胞リンパ腫を発症したATL 第6回日本HTLV-1学会学術集会 第6回日本HTLV-1学会学術集会 2019/08/24 Disclose to all
Killer immunoglobulin-like receptor (KIR)で読み解く臨床免疫学[Invited] Killer immunoglobulin-like receptor (KIR)で読み解く臨床免疫学 [Invited] 第17回日本組織適合性学会近畿地方会 第17回日本組織適合性学会近畿地方会 2019/03/02 Japanese Symposium workshop panel(nominated) Disclose to all
慢性骨髄性白血病におけるチロシンキナーゼ阻害剤の効果はKIRおよびHLAのアリル多型と相関する[Invited] 慢性骨髄性白血病におけるチロシンキナーゼ阻害剤の効果はKIRおよびHLAのアリル多型と相関する [Invited] 第46回日本臨床免疫学会総会 第46回日本臨床免疫学会総会 2018/11/08 Japanese Symposium workshop panel(nominated) Disclose to all
Phosphorylation of ERK1/2 in CD4+ T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation CD4 T細胞におけるERK1/2のリン酸化は同種造血幹細胞移植後の急性GVHDと相関する Phosphorylation of ERK1/2 in CD4+ T cells is associated with acute GVHD in allogeneic hematopoietic stem cell transplantation The 80th annual meeting of the Japanese Society of Hematology 第80回日本血液学会学術集会 The 80th annual meeting of the Japanese Society of Hematology 2018/10/12 English Oral presentation(general) Disclose to all
慢性骨髄性白血病におけるKIRとHLAのアリル多型はチロシンキナー ゼ阻害剤の治療効果と相関する 慢性骨髄性白血病におけるKIRとHLAのアリル多型はチロシンキナー ゼ阻害剤の治療効果と相関する 第26回日本組織適合性学会大会 第26回日本組織適合性学会大会 2017/10 Japanese Symposium workshop panel(nominated) Disclose to all
MEK阻害剤トラメチニブはラット肺移植後の胸腺機能を温存しつつ遅発性拒絶を抑制する MEK阻害剤トラメチニブはラット肺移植後の胸腺機能を温存しつつ遅発性拒絶を抑制する 第27回日本組織適合性学会大会 第27回日本組織適合性学会大会 2017/09/21 Japanese Oral presentation(general) Disclose to all
TCR Repertoire, Effector Regulatory T-cells and KIR Genotyping Uncover Immunological Dynamics in Mogamulizumab-treated ATL TCR Repertoire, Effector Regulatory T-cells and KIR Genotyping Uncover Immunological Dynamics in Mogamulizumab-treated ATL TCR Repertoire, Effector Regulatory T-cells and KIR Genotyping Uncover Immunological Dynamics in Mogamulizumab-treated ATL International Conference of Human Retrovirology HTLV and related viruses International Conference of Human Retrovirology HTLV and related viruses International Conference of Human Retrovirology HTLV and related viruses 2017 English Oral presentation(general) Disclose to all
The MEK inhibitor trametinib selectively suppresses GVHD, while sparing GVT and antiviral immunity.[Invited] The MEK inhibitor trametinib selectively suppresses GVHD, while sparing GVT and antiviral immunity. [Invited] The MEK inhibitor trametinib selectively suppresses GVHD, while sparing GVT and antiviral immunity. [Invited] The 7th Japanese Society of Hematology (JSH) International Symposium The 7th Japanese Society of Hematology (JSH) International Symposium The 7th Japanese Society of Hematology (JSH) International Symposium 2016/05/14 English Oral presentation(keynote) Disclose to all
The MEK inhibitor trametinib selectively suppresses GVHD, while sparing GVT effects. The MEK inhibitor trametinib selectively suppresses GVHD, while sparing GVT effects. The MEK inhibitor trametinib selectively suppresses GVHD, while sparing GVT effects. Biol Blood Marrow Transplant Biol Blood Marrow Transplant Biol Blood Marrow Transplant 2015/02 English Oral presentation(general) Disclose to all
Trametinib selectively inhibits alloreactivity while sparing virus-specific T cells. Trametinib selectively inhibits alloreactivity while sparing virus-specific T cells. Trametinib selectively inhibits alloreactivity while sparing virus-specific T cells. Biol Blood Marrow Transplant Biol Blood Marrow Transplant Biol Blood Marrow Transplant 2014/02 English Oral presentation(general) Disclose to all

  • <<
  • >>
Title language:
Awards
Title(Japanese) Title(English) Organization name(Japanese) Organization name(English) Date
Best Post-doctoral fellow University of Miami Sylvester Poster Session 2011/08/01
Abstract Achievement Award American Society of Hematology (ASH) The 53rd Annual Meeting of the American Society of Hematology (ASH) 2011/12/01
麒麟児賞 Kirinji Award 第9回血液学若手研究者勉強会 The 9th Meeting of young investigators in hematology (KIRIN-JUKU) 2013/07/01
一般研究助成 Grant-in-aid for Medical Research 日本白血病研究基金 Japan Leukemia Research Fund (JLRF) 2013/11/08
一般研究助成 Grant-in-aid for Medical Research 先進医薬研究振興財団 SENSHIN Medical Research Foundation 2013/12/01
一般研究助成 Grant-in-aid for Medical Research 武田科学振興財団 Takeda Science Foundation 2016/11/19
一般研究助成 Grant-in-aid for Medical Research 先進医薬研究振興財団 SENSHIN Medical Research Foundation 2016/12/01
一般研究助成 Grant-in-aid for Medical Research 小林がん学術振興財団 Kobayashi Cancer Research Foundation 2017/06/17
学術奨励賞(優秀賞) Encouragement Award 第26回日本組織適合性学会大会 The 26th annual meeting of the Japanese Society of Histocompatibility and Immunogenetics 2017/10/28
京都大学医学部附属病院病院長賞 Kyoto University Hospital President's Award 京都大学医学部附属病院 Kyoto University Hospital 2019/03/31
External funds: competitive funds and Grants-in-Aid for Scientific Research (Kakenhi)
Type Position Title(Japanese) Title(English) Period
科研費:基盤研究C Representative MEK阻害剤を用いた移植後GVHDの選択的抑制と感染・腫瘍免疫の温存 2013/04/01-2017/03/31
AMED橋渡し研究シーズプログラム・シーズA Assignment MEK阻害剤トラメチニブを用いた肺移植後慢性拒絶の抑制 2017/04/01-2018/03/31
AMED橋渡し研究シーズプログラム・シーズA Representative コビメチニブを用いた造血幹細胞移植後の免疫再構築促進 2018/04/01-2019/03/31
科研費・基盤研究B Assignment 肺移植後の慢性拒絶撲滅を目指す、自然免疫を温存した選択的免疫抑制療法の創出 2018/04/01-2021/03/31
科研費・基盤研究C Representative KIRアリル多型に着目した造血幹細胞移植における免疫の最適化 2019/04/01-2022/03/31
基盤研究(C) Representative KIRアリル多型に着目した造血幹細胞移植における免疫の最適化 (2019年度分) 2019/04/01-2020/03/31
基盤研究(C) Representative KIRアリル多型に着目した造血幹細胞移植における免疫の最適化 (2020年度分) 2020/04/01-2021/03/31
External funds: other than those above
System Main person Title(Japanese) Title(English) Period
日本白血病研究基金 進藤岳郎 MEK阻害剤を用いたGVHDの選択的抑制と抗腫瘍免疫の温存 2013/12/01-2014/11/30
先進医薬研究振興財団 進藤岳郎 MEK阻害剤を用いたGVHDの選択的抑制と抗腫瘍免疫の温存 2013/12/01-
武田科学振興財団 進藤岳郎 MEK阻害剤を用いた造血幹細胞移植後免疫抑制の最適化 2016/11/19-
先進医薬研究振興財団 進藤岳郎 MEK阻害剤を用いた造血幹細胞移植後免疫抑制の最適化 2016/12/01-
一般研究助成 進藤岳郎 MEK阻害剤を用いた造血幹細胞移植後免疫抑制の最適化 2017/06/17-
ノバルティス研究助成金 進藤岳郎 KIRアリル多型に着目した造血幹細胞移植の最適化 2018/10/01-
上原記念生命科学財団・研究助成金 進藤岳郎 同種造血幹細胞移植におけるKIRアレルの機能解析 2019/03/01-2020/02/28
Awards received by supervised students
Student name Award title Giver Date
板村英和 ベストポスター賞 がん分子標的治療学会 2015/07/
板村英和 一般研究助成 かなえ財団 2016/03/01
板村英和 佐賀大学医学部内科同門会賞 佐賀大学医学部 2016/03/
嬉野博志 優秀論文賞 佐賀大学 2017/03/24
板村英和 海外留学助成 上原記念財団 2017/04/01
嬉野博志 佐賀大学医学部長賞 佐賀大学 2019/03/01
嬉野博志 佐賀大学内科同門会賞 佐賀大学 2019/03/01
蒲池和晴 宇都宮賞 日本HTLV-1学会 2019/08/24
多田誠一郎 Apply and Do演題 日本移植学会 2019/10/
櫻田紘基 優秀発表賞 第110回近畿血液学地方会 2019/11/16
Academic organizaions (conference chair)
Organization name Group name Date
日本造血細胞移植学会 年次学術集会 2014/03/
日本血液学会 第78回日本血液学会学術集会 2016/10/18
日本血液学会 第79回日本血液学会学術集会 2017/10/21
日本癌学会 第78回日本癌学会学術集会 2019/09/28
日本血液学会 第81回日本血液学会学術集会 2019/10/11
Other activities (private companies, NPOs, etc.)
Company name Activity Period
Cancer Net Japan AKIBA Cancer Forumでの啓発講演 2015/08/05-2015/08/05
つばさフォーラム京都 血液疾患に関する啓発講演 2017/07/29-2017/07/29
つばさフォーラム京都 血液疾患に関する啓発講演 2018/08/25-2018/08/25
関西HTLV-1ねっと 講演 2019/03/17-2019/03/17
つばさフォーラム京都 血液疾患に関する啓発講演 2019/08/24-2019/08/24